Rekah Pharmaceutical Industry Ltd. (REKA.TA)
ILA 1176.0
(-1.26%)
ILA 1176.0
(-1.26%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 159.59 Million ILS | 18.95% |
| 2022 | 134.16 Million ILS | -8.87% |
| 2021 | 147.22 Million ILS | 13.73% |
| 2020 | 129.44 Million ILS | 9.05% |
| 2019 | 118.7 Million ILS | 125.66% |
| 2018 | 52.6 Million ILS | -4.43% |
| 2017 | 55.03 Million ILS | -13.2% |
| 2016 | 63.41 Million ILS | -12.64% |
| 2015 | 72.58 Million ILS | -50.43% |
| 2014 | 146.44 Million ILS | 11.38% |
| 2013 | 131.48 Million ILS | 3186.41% |
| 2012 | -4.26 Million ILS | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 162.35 Million ILS | 1.73% |
| 2024 Q2 | 126.86 Million ILS | -21.86% |
| 2023 Q2 | 142.33 Million ILS | 2.84% |
| 2023 FY | 159.59 Million ILS | 18.95% |
| 2023 Q1 | 138.4 Million ILS | 3.16% |
| 2023 Q4 | 159.59 Million ILS | 2.85% |
| 2023 Q3 | 155.16 Million ILS | 9.02% |
| 2022 FY | 134.16 Million ILS | -8.87% |
| 2022 Q2 | 134.82 Million ILS | -0.37% |
| 2022 Q3 | 145.03 Million ILS | 7.57% |
| 2022 Q4 | 134.16 Million ILS | -7.49% |
| 2022 Q1 | 135.33 Million ILS | -8.08% |
| 2021 FY | 147.22 Million ILS | 13.73% |
| 2021 Q4 | 147.22 Million ILS | -4.26% |
| 2021 Q3 | 153.77 Million ILS | 22.74% |
| 2021 Q1 | 117.9 Million ILS | -8.92% |
| 2021 Q2 | 125.28 Million ILS | 6.26% |
| 2020 Q3 | 134.94 Million ILS | 23.5% |
| 2020 Q1 | 118.62 Million ILS | -0.06% |
| 2020 Q2 | 109.27 Million ILS | -7.88% |
| 2020 Q4 | 129.44 Million ILS | -4.07% |
| 2020 FY | 129.44 Million ILS | 9.05% |
| 2019 Q3 | 106.83 Million ILS | 64.5% |
| 2019 FY | 118.7 Million ILS | 125.66% |
| 2019 Q2 | 64.94 Million ILS | 4.05% |
| 2019 Q1 | 62.41 Million ILS | 18.66% |
| 2019 Q4 | 118.7 Million ILS | 11.11% |
| 2018 Q1 | 64.97 Million ILS | 18.06% |
| 2018 Q4 | 52.6 Million ILS | -15.16% |
| 2018 Q3 | 62 Million ILS | -2.3% |
| 2018 Q2 | 63.45 Million ILS | -2.34% |
| 2018 FY | 52.6 Million ILS | -4.43% |
| 2017 Q3 | 56.5 Million ILS | -1.53% |
| 2017 FY | 55.03 Million ILS | -13.2% |
| 2017 Q2 | 57.38 Million ILS | -10.5% |
| 2017 Q1 | 64.11 Million ILS | 1.1% |
| 2017 Q4 | 55.03 Million ILS | -2.6% |
| 2016 Q1 | 87.15 Million ILS | 20.07% |
| 2016 FY | 63.41 Million ILS | -12.64% |
| 2016 Q4 | 63.41 Million ILS | -11.06% |
| 2016 Q3 | 71.29 Million ILS | 8.96% |
| 2016 Q2 | 65.43 Million ILS | -24.92% |
| 2015 FY | 72.58 Million ILS | -50.43% |
| 2015 Q4 | 72.58 Million ILS | 1.76% |
| 2015 Q3 | 71.33 Million ILS | 19.07% |
| 2015 Q2 | 59.9 Million ILS | -57.35% |
| 2015 Q1 | 140.45 Million ILS | -4.09% |
| 2014 Q1 | 130.88 Million ILS | -0.45% |
| 2014 FY | 146.44 Million ILS | 11.38% |
| 2014 Q4 | 146.44 Million ILS | 5.62% |
| 2014 Q3 | 138.65 Million ILS | 2.03% |
| 2014 Q2 | 135.89 Million ILS | 3.83% |
| 2013 Q1 | 133.79 Million ILS | 3240.8% |
| 2013 Q3 | 133.49 Million ILS | 0.75% |
| 2013 FY | 131.48 Million ILS | 3186.41% |
| 2013 Q2 | 132.49 Million ILS | -0.97% |
| 2013 Q4 | 131.48 Million ILS | -1.5% |
| 2012 FY | -4.26 Million ILS | 0.0% |
| 2012 Q4 | -4.26 Million ILS | 1.43% |
| 2012 Q3 | -4.32 Million ILS | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Cannabotech LTD | 1.05 Million ILA | -14998.392% |